Samsung Epis Holdings Reports Q3 Revenue of KRW 441.9B, Operating Profit of KRW 105.0B
Samsung Bioepis reported Q3 revenue of KRW 442.2B and operating profit of KRW 132.6B. Its nine-month operating profit was KRW 363.2B, equal to 97% of FY25.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.